Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
Webinars

The Use of Chronic Erythrocytapheresis for Iron Overload Management in SCD

Here’s what you can expect:

  • Become familiar with chronic transfusion protocols for sickle cell disease (SCD)
  • Understand why iron overload is a consequence of simple transfusion therapy without chelation that can be managed with erythrocytapheresis
  • Review iron overload mitigation strategies
  • Gain new insight into best practices in chronic transfusion therapies


Duration: 40-minute recorded presentation, including a 20-minute Q&A


VIEW WEBINAR


About The Presenter:
Ross M. Fasano, MD

Pediatric Hematologist and Director of Apheresis,
Children’s Healthcare of Atlanta;
Assistant Professor, Department of Pathology and
Laboratory Medicine, Emory University School of Medicine

​​​​​​​​​​​​​​​​​​​​​​​​​​

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}